# Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

> **NCT03865888** · PHASE3 · COMPLETED · sponsor: **Pavly Moawd** · enrollment: 60 (actual)

## Conditions studied

- Dry Eye
- Sjogren Syndrome

## Interventions

- **DRUG:** Cyclosporins
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT03865888
- **Lead sponsor:** Pavly Moawd
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-30
- **Primary completion:** 2019-02-01
- **Final completion:** 2019-04-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03865888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03865888, "Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03865888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*